Equities

Senti Biosciences Inc

SNTI:NAQ

Senti Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.27
  • Today's Change0.03 / 1.34%
  • Shares traded7.79k
  • 1 Year change-56.23%
  • Beta2.7342
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income(71)(58)(55)
Depreciation/depletion3.561.400.77
Non-Cash items108.0119
Cash taxes paid, supplemental------
Cash interest paid, supplemental------
Changes in working capital4.67140.62
Total cash from operations(52)(35)(35)
INVESTING
Capital expenditures(12)(41)(5.54)
Other investing and cash flow items, total42(41)--
Total cash from investing30(82)(5.54)
FINANCING
Financing cash flow items0117(0.07)
Total cash dividends paid------
Issuance (retirement) of stock, net0.891.4069
Issuance (retirement) of debt, net(0.11)----
Total cash from financing0.7811968
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(22)1.7028
Net cash-begin balance/reserved for future use615931
Net cash-end balance/reserved for future use396159
SUPPLEMENTAL INCOME
Depreciation, supplemental3.561.400.77
Cash interest paid, supplemental------
Cash taxes paid, supplemental------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.